Results 171 to 180 of about 26,122 (235)

High Expression of SSEA3 and Globo H Predicts Poor Outcomes in Resected Extrahepatic Cholangiocarcinoma: A Single-Center Retrospective Cohort Study. [PDF]

Cancer Med
Hung TH, Hung JT, Yeh CN, Hsieh RC, Hsu SC, Yu AL, Huang Y.   +6 more
europepmc   +1 more source

Identification of GCNT3 as a glycometabolism-associated biomarker in endometrial cancer. [PDF]

Sci Rep
Ke D, Li W, Xu J, He X, Wang Y, Tan J, Sun Y.   +6 more
europepmc   +1 more source

Central Roles of Glucosylceramide in Driving Cancer Pathogenesis. [PDF]

Int J Mol Sci
Zhao X, Pandey MK.
europepmc   +1 more source

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]

Front Pharmacol
Gómez-Cebrián N, Trull MC, Gras-Colomer E, Edo Solsona MD, Poveda Andrés JL, Puchades-Carrasco L.   +5 more
europepmc   +1 more source

Novel Genomes of <i>Sphingomonadales</i> Strains Isolated from Diverse Environments. [PDF]

Microorganisms
Williams NW, Ali T, Boudreau PD.
europepmc   +1 more source

The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis. [PDF]

Int J Mol Sci
Jennemann R, Sandhoff R.
europepmc   +1 more source

Glycosphingolipids in cestodes

, 1992
Wiegandt, H., Geyer, E., Egge, H., Hartmann, R., Peter-Katalinic, J., Geyer, R., Baumeister, St., Dennis, R. D.   +7 more
openaire   +1 more source